Journal of pain and symptom management
-
J Pain Symptom Manage · Jun 2016
Review Multicenter Study Meta AnalysisPrevalence of Neuropathic Pain in Cancer Patients: Pooled Estimates From a Systematic Review of Published Literature and Results From a Survey Conducted in Fifty Italian Palliative Care Centers.
Because of the increasing body of literature on neuropathic cancer pain (NCP), an accurate estimate of its prevalence requires recurring updates. ⋯ The systematic review and the survey suggest that more than one in three patients with cancer pain also experiences NCP.
-
J Pain Symptom Manage · Jun 2016
Prescription and Deprescription of Medication During the Last 48 Hours of Life: Multicenter Study in 23 Acute Geriatric Wards in Flanders, Belgium.
Palliative care for the older person is often limited, resulting in poor quality of dying. Pharmacological management can be one of the components to achieve better symptom control. ⋯ Anticipatory prescription of medication and deprescription of medication at the end of life in acute geriatric wards could be further optimized. A well-developed intervention to guide health care staff in patient-centered pharmacological management in the last days of life seems to be needed.
-
J Pain Symptom Manage · Jun 2016
Review Meta AnalysisUpdate on Prevalence of Pain in Patients with Cancer: Systematic Review and Meta-Analysis.
Cancer pain has a severe impact on quality of life and is associated with numerous psychosocial responses. Recent studies suggest that treatment of cancer pain has improved during the last decade. ⋯ Despite increased attention on assessment and management, pain continues to be a prevalent symptom in patients with cancer. In the upcoming decade, we need to overcome barriers toward effective pain treatment and develop and implement interventions to optimally manage pain in patients with cancer.
-
J Pain Symptom Manage · Jun 2016
Randomized Controlled Trial Multicenter StudySaw Palmetto for Symptom Management During Radiation Therapy for Prostate Cancer.
Lower urinary tract symptoms (LUTSs) affect 75%-80% of men undergoing radiation therapy (RT) for prostate cancer. ⋯ SP at 960 mg may be a safe herbal supplement, but its efficacy in managing LUTS during RT needs further investigation.